HY-125975-1mg
|
MedChemexpress LLC
|
1-Naphthyl 3,5-dinitrobenzoate [CAS 93261-39-3]
|
|
|
|
HY-136527-1mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-10mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-100mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-25mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-5mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-136527-50mg
|
MedChemexpress LLC
|
BMS-986251 [CAS 2460133-35-9]
|
|
COVID-19-immunoregulation
|
|
HY-148748-10mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-100mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-25mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-5mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-148748-50mg
|
MedChemexpress LLC
|
Butyzamide [CAS 1110767-45-7]
|
|
COVID-19-immunoregulation
|
|
HY-120878-10mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-100mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-25mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-5mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-50mg
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9]
|
|
COVID-19-immunoregulation
|
|
HY-120878-1mL
|
MedChemexpress LLC
|
CXCR2-IN-2 [CAS 1838123-21-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-111551-10mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-100mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-5mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-50mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
HY-111551-1mL
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-100131-10mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-100mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|